| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Laboratory of Biochemical Risk Analysis [D. A. B., E. A. S., T. C., M. W.] and Statistics and Biomathematics Branch [D. M. U.], National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina 27709; Department of Surgery, School of Postgraduate Medicine, Keele University, North Staffordshire Hospital, Stoke-on-Trent, Staffordshire, England [M. D., J. E., C. H.]; and Clinical Biochemistry Research Laboratory, School of Postgraduate Medicine, Keele University, North Staffordshire Hospital, Stoke-on-Trent, Staffordshire, England TS4 7QB[H. D., R. C. S.]
Exposure to carcinogens present in the diet, cigarette smoke, or the environment may be associated with increased risk of colorectal cancer. Aromatic amines (aryl- and heterocyclic) are a class of carcinogens that are important in these exposures. These compounds can be N- or O-acetylated by the NAT1 or NAT2 enzymes, resulting in activation or in some cases detoxification. Recent studies have shown that both NAT2 and NAT1 genes exhibit variation in human populations and that rapid acetylation by the NAT2 enzyme may be a risk factor for colorectal cancer. In this study we have analyzed for genetic polymorphism in both NAT1 and NAT2 in a group of 202 colorectal cancer patients and 112 control subjects from Staffordshire, England. We find significantly increased risk (odds ratio, 1.9; 95% confidence interval, 1.23.2; P = 0.009) associated with the NAT1*10 allele of NAT1, an allele that contains a variant polyadenylation signal. Individuals with higher stage tumors (Duke's C) were more likely to inherit this variant allele (odds ratio, 2.5; 95% confidence interval, 1.34.7; P = 0.005). In contrast, rapid acetylation genotypes of NAT2 were not a significant risk factor in this English population. However, we found that the risk associated with the NAT1 variant allele (NAT1*10) was most apparent among NAT2 rapid acetylators (odds ratio, 2.8; 95% confidence interval, 1.45.7; P = 0.003), suggesting a possible gene-gene interaction between NAT1 and NAT2 (test for interaction; P = 0.12). This is the first study to test for cancer risk associated with the NAT1 gene, and these positive findings suggest that NAT1 alleles may be important genetic determinents of colorectal cancer risk.
1 To whom requests for reprints should be addressed, at C3-03, National Institute of Environmental Health Sciences, P.O. Box 12233, Research Triangle Park, NC 27709.
Received 2/23/95. Accepted 6/ 8/95.
This article has been cited by other articles:
![]() |
H. E. Liu, P.-Y. Hsiao, C.-C. Lee, J.-A. Lee, and H.-Y. Chen NAT2*7 Allele Is a Potential Risk Factor for Adult Brain Tumors in Taiwanese Population Cancer Epidemiol. Biomarkers Prev., March 1, 2008; 17(3): 661 - 665. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. P. Perera, D. Tang, P. Brandt-Rauf, R. M. Santella, L. V. A. Mooney, Y.-H. Tu, I. Bendkowska, and D. A. Bell Lack of Associations among Cancer and Albumin Adducts, ras p21 Oncoprotein Levels, and CYP1A1, CYP2D6, NAT1, and NAT2 in a Nested Case-Control Study of Lung Cancer within the Physicians' Health Study. Cancer Epidemiol. Biomarkers Prev., July 1, 2006; 15(7): 1417 - 1419. [Full Text] [PDF] |
||||
![]() |
C. Lilla, E. Verla-Tebit, A. Risch, B. Jager, M. Hoffmeister, H. Brenner, and J. Chang-Claude Effect of NAT1 and NAT2 Genetic Polymorphisms on Colorectal Cancer Risk Associated with Exposure to Tobacco Smoke and Meat Consumption Cancer Epidemiol. Biomarkers Prev., January 1, 2006; 15(1): 99 - 107. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Li, L. Jiao, Y. Li, M. A. Doll, D. W. Hein, M. L. Bondy, D. B. Evans, R. A. Wolff, R. Lenzi, P. W. Pisters, et al. Polymorphisms of cytochrome P4501A2 and N-acetyltransferase genes, smoking, and risk of pancreatic cancer Carcinogenesis, January 1, 2006; 27(1): 103 - 111. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Danckwardt, N. H. Gehring, G. Neu-Yilik, P. Hundsdoerfer, M. Pforsich, U. Frede, M. W. Hentze, and A. E. Kulozik The prothrombin 3'end formation signal reveals a unique architecture that is sensitive to thrombophilic gain-of-function mutations Blood, July 15, 2004; 104(2): 428 - 435. [Abstract] [Full Text] [PDF] |
||||
![]() |
M D Crabtree, C Fletcher, M Churchman, S V Hodgson, K Neale, R K S Phillips, and I P M Tomlinson Analysis of candidate modifier loci for the severity of colonic familial adenomatous polyposis, with evidence for the importance of the N-acetyl transferases Gut, February 1, 2004; 53(2): 271 - 276. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Schroeder, K. Conway, Y. Li, K. Mistry, D. A. Bell, and J. A. Taylor p53 Mutations in Bladder Cancer: Evidence for Exogenous versus Endogenous Risk Factors Cancer Res., November 1, 2003; 63(21): 7530 - 7538. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. K. Cortessis, K. Siegmund, S. Xue, R. K. Ross, and M. C. Yu A case-control study of cyclin D1 CCND1 870A->G polymorphism and bladder cancer Carcinogenesis, October 1, 2003; 24(10): 1645 - 1650. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Gago-Dominguez, D. A. Bell, M. A. Watson, J.-M. Yuan, J.E. Castelao, D. W. Hein, K. K. Chan, G. A. Coetzee, R. K. Ross, and M. C. Yu Permanent hair dyes and bladder cancer: risk modification by cytochrome P4501A2 and N-acetyltransferases 1 and 2 Carcinogenesis, March 1, 2003; 24(3): 483 - 489. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. de Jong, I. M. Nolte, G. J. te Meerman, W. T. A. van der Graaf, E. G. E. de Vries, R. H. Sijmons, R. M. W. Hofstra, and J. H. Kleibeuker Low-penetrance Genes and Their Involvement in Colorectal Cancer Susceptibility Cancer Epidemiol. Biomarkers Prev., November 1, 2002; 11(11): 1332 - 1352. [Abstract] [Full Text] [PDF] |
||||
![]() |
M M de Jong, I M Nolte, G J te Meerman, W T A van der Graaf, J C Oosterwijk, J H Kleibeuker, M Schaapveld, and E G E de Vries Genes other than BRCA1 and BRCA2 involved in breast cancer susceptibility J. Med. Genet., April 1, 2002; 39(4): 225 - 242. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Le Marchand, J. H. Hankin, L. R. Wilkens, L. M. Pierce, A. Franke, L. N. Kolonel, A. Seifried, L. J. Custer, W. Chang, A. Lum-Jones, et al. Combined Effects of Well-done Red Meat, Smoking, and Rapid N-Acetyltransferase 2 and CYP1A2 Phenotypes in Increasing Colorectal Cancer Risk Cancer Epidemiol. Biomarkers Prev., December 1, 2001; 10(12): 1259 - 1266. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Fronhoffs, T. Bruning, E. Ortiz-Pallardo, P. Brode, B. Koch, V. Harth, A. Sachinidis, H. M. Bolt, C. Herberhold, H. Vetter, et al. Real-time PCR analysis of the N-acetyltransferase NAT1 allele *3, *4, *10, *11, *14 and *17 polymorphism in squamous cell cancer of head and neck Carcinogenesis, September 1, 2001; 22(9): 1405 - 1412. [Abstract] [Full Text] [PDF] |
||||
![]() |
M-W Yu, C-I Pai, S-Y Yang, T-J Hsiao, H-C Chang, S-M Lin, Y-F Liaw, P-J Chen, and C-J Chen Role of N-acetyltransferase polymorphisms in hepatitis B related hepatocellular carcinoma: impact of smoking on risk Gut, November 1, 2000; 47(5): 703 - 709. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. S. King, C. H. Teitel, and F. F. Kadlubar In vitro bioactivation of N-hydroxy-2-amino-{alpha}-carboline Carcinogenesis, July 1, 2000; 21(7): 1347 - 1354. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Krajinovic, C. Richer, H. Sinnett, D. Labuda, and D. Sinnett Genetic Polymorphisms of N-Acetyltransferases 1 and 2 and Gene-Gene Interaction in the Susceptibility to Childhood Acute Lymphoblastic Leukemia Cancer Epidemiol. Biomarkers Prev., June 1, 2000; 9(6): 557 - 562. [Abstract] [Full Text] |
||||
![]() |
N. M. Probst-Hensch, D. A. Bell, M. A. Watson, P. L. Skipper, S. R. Tannenbaum, K. K. Chan, R. K. Ross, and M. C. Yu N-Acetyltransferase 2 Phenotype but not NAT1*10 Genotype Affects Aminobiphenyl-Hemoglobin Adduct Levels Cancer Epidemiol. Biomarkers Prev., June 1, 2000; 9(6): 619 - 623. [Abstract] [Full Text] |
||||
![]() |
R. J. Delfino, R. Sinha, C. Smith, J. West, E. White, H. J. Lin, S.-Y. Liao, J. S.Y. Gim, H. L. Ma, J. Butler, et al. Breast cancer, heterocyclic aromatic amines from meat and N-acetyltransferase 2 genotype Carcinogenesis, April 1, 2000; 21(4): 607 - 615. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. F. Olshan, M. C. Weissler, M. A. Watson, and D. A. Bell GSTM1, GSTT1, GSTP1, CYP1A1, and NAT1 Polymorphisms, Tobacco Use, and the Risk of Head and Neck Cancer Cancer Epidemiol. Biomarkers Prev., February 1, 2000; 9(2): 185 - 191. [Abstract] [Full Text] |
||||
![]() |
D. W. Hein, M. A. Doll, A. J. Fretland, M. A. Leff, S. J. Webb, G. H. Xiao, U.-S. Devanaboyina, N. A. Nangju, and Y. Feng Molecular Genetics and Epidemiology of the NAT1 and NAT2 Acetylation Polymorphisms Cancer Epidemiol. Biomarkers Prev., January 1, 2000; 9(1): 29 - 42. [Abstract] [Full Text] |
||||
![]() |
L. L. Marchand Combined Influence of Genetic and Dietary Factors on Colorectal Cancer Incidence in Japanese Americans J Natl Cancer Inst Monographs, December 1, 1999; 1999(26): 101 - 105. [Abstract] [Full Text] |
||||
![]() |
G. J. Stevens, M. Payton, E. Sim, and C. A. McQueen N-Acetylation of the Heterocyclic Amine Batracylin by Human Liver Drug Metab. Dispos., September 1, 1999; 27(9): 966 - 971. [Abstract] [Full Text] |
||||
![]() |
J. D. Potter Colorectal Cancer: Molecules and Populations J Natl Cancer Inst, June 2, 1999; 91(11): 916 - 932. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Zheng, A. C. Deitz, D. R. Campbell, W.-Q. Wen, J. R. Cerhan, T. A. Sellers, A. R. Folsom, and D. W. Hein N-Acetyltransferase 1 Genetic Polymorphism, Cigarette Smoking, Well-Done Meat Intake, and Breast Cancer Risk Cancer Epidemiol. Biomarkers Prev., March 1, 1999; 8(3): 233 - 239. [Abstract] [Full Text] [PDF] |
||||
![]() |
D Hickman, J Pope, S D Patil, G Fakis, V Smelt, L A Stanley, M Payton, J D Unadkat, and E Sim Expression of arylamine N-acetyltransferase in human intestine Gut, March 1, 1998; 42(3): 402 - 409. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |